2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow ISIS 329993: new trials by email Literature Review of ISIS 329993 trials Research Report on ISIS 329993
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation ISIS CRP Rx, Placebo - Paroxysmal Atrial Fibrillation | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 7 | 2012-10-01 | 2015-08-26 |
| Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis ISIS CRP Rx or Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Ionis Pharmaceuticals, Inc. | 51 | 2011-08-01 | 2013-05-17 |
Arthritis, Rheumatoid (1) · Atrial Fibrillation (1)
Ionis Pharmaceuticals, Inc. (2)
Canada (1) · Russia (1) · United Kingdom (1)